MedTrace Logo

The Effect of Nanofat Injection on Androgenetic Alopecia

NCT07518342 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-04-13

No results posted yet for this study

Summary

Androgenetic alopecia is a condition that bothers a lot of people. The disadvantage of the FDA approved topical minoxidil is that the patient needs to be compliant every day for extended periods of time. This is the main reason why this study is being conducted, to see if a single nanofat injection is superior to applying either topical Minoxidil or PRP

Conditions

Interventions

DRUG

Minoxidil 5 %

Topical application of minoxidil 5%

PROCEDURE

PRP injection

3 PRP injections one month apart

PROCEDURE

Nanofat injection

Single nanofat injection

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hanan Ahmed Morsy, Professor Doctor · Assiut University

  • Reham Maher Abdel Gaber, Doctor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07518342 on ClinicalTrials.gov